A robust Platform for Integrative Spatial Multi-omics Analysis to Map Immune Responses to SARS-CoV-2 infection in Lung Tissues

The SARS-CoV-2 (COVID-19) virus has caused a devastating global pandemic of respiratory illness. To understand viral pathogenesis, methods are available for studying dissociated cells in blood, nasal samples, bronchoalveolar lavage fluid, and similar, but a robust platform for deep tissue characterisation of molecular and cellular responses to virus infection in the lungs is still lacking. We developed an innovative spatial multi-omics platform to investigate COVID-19-infected lung tissues. Five tissue-profiling technologies were combined by a novel computational mapping methodology to comprehensively characterise and compare the transcriptome and targeted proteome of virus infected and uninfected tissues. By integrating spatial transcriptomics data (Visium, GeoMx and RNAScope) and proteomics data (CODEX and PhenoImager HT) at different cellular resolutions across lung tissues, we found strong evidence for macrophage infiltration and defined the broader microenvironment surrounding these cells. By comparing infected and uninfected samples, we found an increase in cytokine signalling and interferon responses at different sites in the lung and showed spatial heterogeneity in the expression level of these pathways. These data demonstrate that integrative spatial multi-omics platforms can be broadly applied to gain a deeper understanding of viral effects on cellular environments at the site of infection and to increase our understanding of the impact of SARS-CoV-2 on the lungs.

[1]  Sibusiso B. Maseko,et al.  A proteome-scale map of the SARS-CoV-2–human contactome , 2022, Nature Biotechnology.

[2]  H. Soyer,et al.  A robust experimental and computational analysis framework at multiple resolutions, modalities and coverages , 2022, Frontiers in Immunology.

[3]  N. Stoecklein,et al.  StarDist Image Segmentation Improves Circulating Tumor Cell Detection , 2022, Cancers.

[4]  J. Reichardt,et al.  COVID-19 2022 update: transition of the pandemic to the endemic phase , 2022, Human genomics.

[5]  M. Hejazi,et al.  COVID-19 infection: an overview on cytokine storm and related interventions , 2022, Virology Journal.

[6]  Shivashankar H. Nagaraj,et al.  Unlocking capacities of genomics for the COVID-19 response and future pandemics , 2022, Nature Methods.

[7]  T. Guo,et al.  Multi-omics in COVID-19: Seeing the unseen but overlooked in the clinic , 2022, Cell Reports Medicine.

[8]  P. Danaher,et al.  Advances in mixed cell deconvolution enable quantification of cell types in spatial transcriptomic data , 2022, Nature Communications.

[9]  T. Peto,et al.  Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants , 2022, The New England journal of medicine.

[10]  Å. Wheelock,et al.  Multiomics integration-based molecular characterizations of COVID-19 , 2021, Briefings Bioinform..

[11]  Chin Wee Tan,et al.  IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study , 2021, Frontiers in Immunology.

[12]  Chin Wee Tan,et al.  Profiling of lung SARS-CoV-2 and influenza virus infection dissects virus-specific host responses and gene signatures , 2020, European Respiratory Journal.

[13]  P. Kaye,et al.  Post-mortem lung tissue: the fossil record of the pathophysiology and immunopathology of severe COVID-19 , 2021, The Lancet Respiratory Medicine.

[14]  Shuye Zhang,et al.  Multiomics: unraveling the panoramic landscapes of SARS-CoV-2 infection , 2021, Cellular & Molecular Immunology.

[15]  K. Rogers,et al.  Spatial omics and multiplexed imaging to explore cancer biology , 2021, Nature Methods.

[16]  G. Nolan,et al.  CODEX multiplexed tissue imaging with DNA-conjugated antibodies , 2021, Nature Protocols.

[17]  Xiaochen Bo,et al.  clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.

[18]  K. Kehn-Hall,et al.  The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner , 2021, Viruses.

[19]  André F. Rendeiro,et al.  A molecular single-cell lung atlas of lethal COVID-19 , 2021, Nature.

[20]  Timothy L. Tickle,et al.  COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets , 2021, Nature.

[21]  Frances E. Muldoon,et al.  Single-cell multi-omics analysis of the immune response in COVID-19 , 2021, Nature Medicine.

[22]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[23]  Hanlee P. Ji,et al.  A deep learning model for molecular label transfer that enables cancer cell identification from histopathology images , 2021, bioRxiv.

[24]  A. von Kriegsheim,et al.  -------A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS--. , 2021, Wellcome open research.

[25]  N. Greenwald,et al.  DeepCell Kiosk: scaling deep learning–enabled cellular image analysis with Kubernetes , 2021, Nature methods.

[26]  Helio T. Navarro,et al.  Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia , 2020, Nature.

[27]  André F. Rendeiro,et al.  The spatial landscape of lung pathology during COVID-19 progression , 2021, Nature.

[28]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[29]  M. Mann,et al.  Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV , 2020, Nature.

[30]  M. Michael Gromiha,et al.  Multi-omics-based identification of SARS-CoV-2 infection biology and candidate drugs against COVID-19 , 2020, Computers in Biology and Medicine.

[31]  R. Lockey,et al.  Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets , 2020, Journal of Cell Communication and Signaling.

[32]  B. Saha,et al.  Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions , 2020, Life Sciences.

[33]  N. McElvaney,et al.  Characterization of the Inflammatory Response to Severe COVID-19 Illness , 2020, American journal of respiratory and critical care medicine.

[34]  F. Krammer,et al.  SARS-CoV-2 Vaccines: Status Report , 2020, Immunity.

[35]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[36]  Ziv Yaniv,et al.  Image Segmentation, Registration and Characterization in R with SimpleITK. , 2018, Journal of statistical software.

[37]  Åsa M. Wheelock,et al.  Integration of multi-omics datasets enables molecular classification of COPD , 2018, European Respiratory Journal.

[38]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[39]  Luke Zappia,et al.  Clustering trees: a visualization for evaluating clusterings at multiple resolutions , 2018, bioRxiv.

[40]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[41]  J. Aerts,et al.  SCENIC: Single-cell regulatory network inference and clustering , 2017, Nature Methods.

[42]  Davis J. McCarthy,et al.  A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor , 2016, F1000Research.

[43]  Aaron T. L. Lun,et al.  Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R , 2017, Bioinform..

[44]  Aaron T. L. Lun,et al.  From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline , 2016, F1000Research.

[45]  J. Farber.  A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.